Page last updated: 2024-09-04

bcx 1812 and laninamivir

bcx 1812 has been researched along with laninamivir in 3 studies

Compound Research Comparison

Studies
(bcx 1812)
Trials
(bcx 1812)
Recent Studies (post-2010)
(bcx 1812)
Studies
(laninamivir)
Trials
(laninamivir)
Recent Studies (post-2010) (laninamivir)
251121031590

Protein Interaction Comparison

ProteinTaxonomybcx 1812 (IC50)laninamivir (IC50)
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))0.0115
Neuraminidase Influenza A virus (A/RI/5+/1957(H2N2))3.1

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Gubareva, LV; Klimov, AI; Mishin, VP; Nguyen, HT; Sheu, TG1
Chen, B; Lei, Z; Liu, K; Tian, Y; Wang, J; Wang, K; Yang, F; Zhang, H; Zhang, K; Zhao, H; Zhao, X; Zhu, H1
Aljohani, MA; Keil, JM; Rafn, GR; Sahebjam-Atabaki, R; Sun, XL; Turan, IM1

Reviews

1 review(s) available for bcx 1812 and laninamivir

ArticleYear
Sialidase Inhibitors with Different Mechanisms.
    Journal of medicinal chemistry, 2022, 10-27, Volume: 65, Issue:20

    Topics: Antiviral Agents; Biological Products; Enzyme Inhibitors; Humans; N-Acetylneuraminic Acid; Neuraminidase; Oseltamivir; Sialic Acids; Zanamivir

2022

Other Studies

2 other study(ies) available for bcx 1812 and laninamivir

ArticleYear
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Acids, Carbocyclic; Animals; Cell Line; Cyclopentanes; Dogs; Enzyme Assays; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Inhibitory Concentration 50; Neuraminidase; Oseltamivir; Zanamivir

2010
Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor.
    European journal of medicinal chemistry, 2020, Aug-15, Volume: 200

    Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Microbial Sensitivity Tests; Molecular Structure; Neuraminidase; Oseltamivir; Structure-Activity Relationship; Viral Proteins

2020